These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27578041)

  • 1. Prostate cancer: Risk SNPs modulate lncRNAs.
    Stone L
    Nat Rev Urol; 2016 Oct; 13(10):565. PubMed ID: 27578041
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.
    Guo H; Ahmed M; Zhang F; Yao CQ; Li S; Liang Y; Hua J; Soares F; Sun Y; Langstein J; Li Y; Poon C; Bailey SD; Desai K; Fei T; Li Q; Sendorek DH; Fraser M; Prensner JR; Pugh TJ; Pomerantz M; Bristow RG; Lupien M; Feng FY; Boutros PC; Freedman ML; Walsh MJ; He HH
    Nat Genet; 2016 Oct; 48(10):1142-50. PubMed ID: 27526323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs and prostate cancer.
    Misawa A; Takayama KI; Inoue S
    Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
    Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
    Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA in prostate, bladder, and kidney cancer.
    Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
    Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
    Xu YH; Deng JL; Wang G; Zhu YS
    Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
    Chandra Gupta S; Nandan Tripathi Y
    Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNAs in prostate cancer: overview and clinical implications.
    Malik B; Feng FY
    Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.
    Su YJ; Yu J; Huang YQ; Yang J
    Int J Mol Sci; 2015 Jun; 16(6):13322-38. PubMed ID: 26110379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Landscape of Noncoding RNA in Prostate Cancer.
    Hua JT; Chen S; He HH
    Trends Genet; 2019 Nov; 35(11):840-851. PubMed ID: 31623872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
    Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA: "LNCs" to cancer.
    Sültmann H; Diederichs S
    Eur Urol; 2014 Jun; 65(6):1152-3. PubMed ID: 24508069
    [No Abstract]   [Full Text] [Related]  

  • 14. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
    Das R; Feng FY; Selth LA
    Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.
    Yang Z; Guo X; Li G; Shi Y; Li L
    Cancer Lett; 2016 Feb; 371(1):62-70. PubMed ID: 26577810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer-associated lncRNAs.
    Mitobe Y; Takayama KI; Horie-Inoue K; Inoue S
    Cancer Lett; 2018 Apr; 418():159-166. PubMed ID: 29330107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
    Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
    Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association analysis of lncRNA HOTAIR genetic variants and gastric cancer risk in a Chinese population.
    Du M; Wang W; Jin H; Wang Q; Ge Y; Lu J; Ma G; Chu H; Tong N; Zhu H; Wang M; Qiang F; Zhang Z
    Oncotarget; 2015 Oct; 6(31):31255-62. PubMed ID: 26384301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers.
    Brisotto G; Guerrieri R; Colizzi F; Steffan A; Montico B; Fratta E
    Methods Mol Biol; 2021; 2292():73-94. PubMed ID: 33651353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.
    Kan Y; Li B; Yang D; Liu Y; Liu J; Yang C; Mao L
    Discov Med; 2021; 32(165):29-37. PubMed ID: 35219354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.